Press Releases

News Brief

Incheon Mayor visits Samsung Biologics upon Plant 4 expansion

Park Nam-choon, Mayor of Incheon City, visited Samsung Biologics' manufacturing facilities
 

Park Nam-choon, Mayor of Incheon City, visited Samsung Biologics' manufacturing facilities upon the company's recent announcement for its Plant 4 and second Bio Campus. Dr. Tae Han Kim, CEO of Samsung Biologics, met with Mayor Park and government officials to further discuss the necessary governmental support for Samsung Biologics' upcoming expansion plans. 

 

During the meeting, Mayor Park offered support from the city to successfully implement the company's R&D center, Open Innovation center, and also Asia's first state-run bioprocessing research and training institute with aims to further establish Songdo as a world-class biocluster.  

Park Nam-choon, Mayor of Incheon City, visited Samsung Biologics' manufacturing facilities
 

Park Nam-choon, Mayor of Incheon City, visited Samsung Biologics' manufacturing facilities upon the company's recent announcement for its Plant 4 and second Bio Campus. Dr. Tae Han Kim, CEO of Samsung Biologics, met with Mayor Park and government officials to further discuss the necessary governmental support for Samsung Biologics' upcoming expansion plans. 

 

During the meeting, Mayor Park offered support from the city to successfully implement the company's R&D center, Open Innovation center, and also Asia's first state-run bioprocessing research and training institute with aims to further establish Songdo as a world-class biocluster. 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION